Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some short-term impacts from President Donald Trump’s proposed tariffs.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Even your weight loss drugs aren't safe from tariffs )
Also on site :
- Trump advisor expects China trade deal conclusion Monday
- China’s Exports of Rare Earths Jump Despite Shipment Controls
- U.S. Rooftop Solar Giant Sunnova Files for Bankruptcy